Theranostic nanoparticles for cancer and cardiovascular applications.
about
Targeting cancer stem cells by using the nanoparticlesPolymeric Nanostructures for Imaging and TherapyUptake and metabolism of iron oxide nanoparticles in brain cells.Covalent IR820-PEG-diamine nanoconjugates for theranostic applications in cancer.Laminin Receptor-Avid Nanotherapeutic EGCg-AuNPs as a Potential Alternative Therapeutic Approach to Prevent Restenosis.Cancer-Targeted Nanotheranostics: Recent Advances and Perspectives.Multimodality imaging in nanomedicine and nanotheranostics.Doxorubicin-loaded protease-activated near-infrared fluorescent polymeric nanoparticles for imaging and therapy of cancer
P2860
Q26783590-E5E1ED41-293A-4C63-BD4B-0CEED98CCBC5Q30372383-2BBD2FE9-BE46-40DF-B3F5-948F1C11EFBEQ30835947-231AAE80-C2FE-49AC-BA56-2A0FA91C4B9BQ34354141-E7F1E3D8-94BA-4FFE-BC31-94AAFC1D8ED4Q38789241-2A680ADB-C5A1-49C7-8732-005270B5D4B0Q38870923-E1B84088-D556-40E9-8C5B-F7EB701656A6Q38997092-37D24E53-817B-4C49-A9AF-408542BAE209Q59135212-67C6526F-35E8-41EA-9EB8-45F357637F43
P2860
Theranostic nanoparticles for cancer and cardiovascular applications.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Theranostic nanoparticles for cancer and cardiovascular applications.
@en
type
label
Theranostic nanoparticles for cancer and cardiovascular applications.
@en
prefLabel
Theranostic nanoparticles for cancer and cardiovascular applications.
@en
P2093
P2860
P1476
Theranostic nanoparticles for cancer and cardiovascular applications.
@en
P2093
P2860
P304
P356
10.1007/S11095-013-1277-Z
P577
2014-03-05T00:00:00Z